Summary of Kaempferia parviflora
Primary Information, Benefits, Effects, and Important Facts
Kaempferia Parviflora (Thai Ginseng) is a herb that has some historical and medicinal usage for treating metabolic ailments and improving vitality in Thailand and limited to surrounding regions. It is also reported to be an aphrodisiac compound and physical enhancer.
Currently, the research on Thai Ginseng is at a moderate level and starting to get human trials. It appears to be 'healthy' and a good source of a class of bioflavonoid compounds with methoxy groups added to them, known as methoxyflavones.
That being said, the research on its aphrodisiac effects in mice indicate that low doses are weak to moderate in potency and higher doses fail to exert any aphrodisiac effect. It does not appear to increase testosterone in otherwise normal rats (although it may in castrated rats), and although it appears to have a variety of mechanisms to be pro-erectile, these have not been tested for potency in a living system. The mechanism of pro-erectility is fairly unique and interesting, but the one study to investigate whether or not it could inhibit PDE5 (one of the mechanisms of Viagra) failed to establish whether it was selective. Selective PDE5 inhibitors are good pro-erectiles without many side-effects, but the non-selectivity (currently not established) may lead to gastrointestinal side effects.
At least one study has noted that it can increase functionality and cardiovascular performance in otherwise healthy persons over 60, but an acute study in youth failed to find any performance enhancing effects at 1.35g (recommended dose, or at least near it).
Currently, Thai Ginseng seems to be weakly promising on proerectility with the other claims not really being better than other possible supplement choices.
No fake reviews. No selling you supplements. Just evidence-based information on what works
Our free supplement mini-course teaches you what works, what's a waste, and how to achieve your health goals.
Join the over 200,000 people who have gone through this course (saving themselves time and millions of dollars).
Things To Know & Note
How to Take Kaempferia parviflora
Recommended dosage, active amounts, other details
According to traditional usage of Kaempferia Parviflora, 0.5-1 teaspoon of ground power is made into a tea and drank about 1-2 hours before physical performance. This is similar to the recommended daily dose from the Thai traditional medicine institute of 1.2g daily, and the one human study on the matter (failing to note benefit acutely) used 1.35g.
General health protective effects have been noted at lower doses, although not enough evidence exists to suggest an optimal dose.
Want access to the latest supplement & nutrition info?
Updated with the newest scientific research as it comes in, the Examine.com Membership keeps you informed on over 300 supplements and across over 500 health goals and outcomes. Becoming a member gives you full access to our entire professional database on supplement and nutrition research.
If you are looking for straightforward directions and step-by-step instructions on what works - and what's a waste - to help improve your health, then our Supplement Guides are exactly what you need. Each guide gives you information on what to take, when to take, and how much to take - and all of it is backed by science.
Human Effect Matrix
The Human Effect Matrix looks at human studies (it excludes animal and in vitro studies) to tell you what effects kaempferia parviflora has on your body, and how strong these effects are.
|Grade||Level of Evidence [show legend]|
|Robust research conducted with repeated double-blind clinical trials|
|Multiple studies where at least two are double-blind and placebo controlled|
|Single double-blind study or multiple cohort studies|
|Uncontrolled or observational studies only|
Level of Evidence
? The amount of high quality evidence. The more evidence, the more we can trust the results.
Magnitude of effect
? The direction and size of the supplement's impact on each outcome. Some supplements can have an increasing effect, others have a decreasing effect, and others have no effect.
Consistency of research results
? Scientific research does not always agree. HIGH or VERY HIGH means that most of the scientific research agrees.
|Notable||- See study|
|Minor||- See study|
|Minor||- See study|
|-||- See study|
|-||- See study|
|-||- See study|
Get access to the latest research
By becoming an Examine.com Member, you'll have access to all of the latest nutrition research on over 300 supplements across over 500 different health goals, outcomes, conditions, and more.
Scientific Research on Kaempferia parviflora
Click on any below to expand the corresponding section. Click on to collapse it.
Kaempferia parviflora (of the family Zingiberaceae) is a medicinal herb from Thailand that has purported usage as an aphrodisiac as well as general health promotion and stimulation. Other usages touted towards this herb include anti-depressive, anti-peptic ulcer, anti-inflammatory, anti-mutagenic and anti-allergic; it is sometimes referred to as Kra chai Dum or just as a Thai Ginseng (although taxonomically unrelated to Panax Ginseng). It is also sometimes referred to as 'Black Turmeric' due to sharing similar morphology to Curcuma Longa (source of dietary Turmeric), but these two compounds do not have similar bioactives and Kaempferia Parviflora does not have a curcumin content. It should be noted that sources of confusion here is Curcuma Parviflora, another herb with a similar name to both and Kra chai (rather than Kra Chai Dum) being used to refer to Boesenbergia rotunda.
Kaempferia parviflora is Thai Ginseng, and commonly called Black Turmeric (since the root is purplish-black underneath the outer layer) although not related to the common spice Turmeric
The three 'main' methoxyflavonoids 5,7-dimethoxyflavone (DMF) at 0.289%, 5,7,4'-trimethoxyflavone (TMF) at 0.0101% and 3,5,7,3',4'-pentamethoxyflavone (PMF) and a variety of other polymethoxyflavonoids
5-hydroxy-3,7-dimethoxyflavone at 0.0252%; a methoxyflavone that appears to be well reseached but is not one of the 'primary' three
Tetramethylluteolin at 0.0312% (derivative of Luteolin)
Tilianine (Methanolic fragment)
Ayanin at 0.0111%
Retusine at 0.0215%
Sesquiterpenoids 4αα-acetoxycadina-2,9-diene-1,8-dione and 1αα,3αα,4ββ-trihydroxy-9-cadinen-8-one
(2R,3R)-(−)-aromadendrin trimethyl ether (ethanol acetate fragment)
Tamarixetin 3-O-rutinoside (Methanolic fragment)
Syringetin 3-O-rutinoside (Methanolic fragment)
A thermostable lectin (sugar-binding protein) in the rhizome at 0.45%
In general, the 'Kaempferosides' appear to be unique to Kaempferia Parviflora but are not seen as the active ingredients. The methoxyflavones (flavones with methoxy groups attached to them) are seen as the main compounds, with the three known as DMF, TMF, and PMF being most commonly researched. This plant also appears to take standard bioflavonoid compounds and add either methoxy or methyl groups to their structures
In testing oral pharmacokinetics of an ethanolic extract of Kaempferia parviflora given at 250mg/kg (9.44, 9.75, and 10.58 mg/kg of PMF, TMF, and DMF) with another group of rats given injections of the same dose (to assess bioavailability), the following parameters were achieved.
5,7-dimethoxyflavone (DMF) had a Cmax of 0.78+/-0.11ug/mL at a Tmax of 0.76+/-0.4 hours with an AUC of 7.01+/-1.37h/ug/mL and a half-life of 5.85+/-1.72 hours; the overall bioavailability was determined to be 2.1%. 5,7,4'-trimethoxyflavone (TMF) had a Cmax of 0.88+/-0.11ug/mL at a Tmax of 0.85+/-0.40 hours with an AUC of 6.96+/-1.11h/ug/mL and a half-life of 5.04+/-1.10 hours; the bioavailability was 1.75%. 3,5,7,3',4'-pentamethoxyflavone (PMF) had a Cmax of 0.55+/-0.05ug/mL at a Tmax of 1.71+/-0.36 hours with an AUC of 3.65+/-0.63h/ug/mL and a half-life of 3.12+/-1.34 hours; the bioavailability was 3.32%.
The methoxyflavanoids appear to be poorly yet quickly absorbed with a relatively long half-life
The three main methoxyflavones were found in tissues of rats after an acute bolus of 750mg/kg reaching the brain, testes, liver, kidney, and lung.
All three main methoxyflavones had a similar degree of fecal excretion, with PMF and TMF having a high urinary excretion relative to DMF.
Kaempferia parviflora extract can, in vitro alter CYP1A1 (induction; non-competitive), CYP1A2 (induction; mixed competitive), CYP2B (induction; competitive), and CYP2E1 (induction; uncompetitive) without affecting CYP3A enzymes.
The rhizome extract appears to also inhibit the Xanthine Oxidase enzyme to a degree of 38% at 500mcg/mL concentration (underperforming the active control of Allopurinol at 10uM inhibiting 44%). Isolated methoxyflavones were tested on Xanthine Oxidase, and most showed weak inhibitory potential aside from 3',4',5,7-tetramethoxyﬂavone (36% at 400uM) and PMF (54% at 400uM), both still underperforming Allopurinol.
After an acute bolus of 750mg/kg Kaempferia parviflora (9.44, 9.75, and 10.58 mg/kg of PMF, TMF, and DMF), PMF reached the brain with a Cmax of 0.26+/-0.10ug/g and a Tmax of 3.14+/-1.07 hours giving an overall neural AUC of 0.76+/-0.13ug/g/h, TMF reached the brain with a Cmax of 1.43+/-0.58ug/g and a Tmax of 3.43+/-0.98 hours giving an overall neural AUC of 2.50+/-0.37ug/g/h, and DMF reached the brain with a Cmax of 0.96+/-0.37ug/g and a Tmax of 3.14+/-1.07 hours giving an overall neural AUC of 1.91+/-0.56ug/g/h.
Oral administration of Thai Ginseng is able to increase methoxyflavone concentrations in the brain, but slightly due to poor bioavailability
Several compounds from Kaempferia Parviflora have been tested for acetylcholinesterase inhibitory potential at a concentration of 0.1mg/mL (appears to be well above what DMF, TMF, and PMF have been recorded to be in the brain) and noted that Acetylcholinesterase is inhibited weakly by DMF and TMF in the range of 42.6-47.1%. Other compounds were either less effective or wholly ineffective.
butyrylcholinesterase is inhibited most potently by DMF (84.6+/-1.3%) which neared the inhibitory potential of Galantamine as active control (95.5+/-1.4%); other notable inhibitions were TMF (46.2+/-1.4%) and 5-hydroxy-7,4'-dimethoxyﬂavone (22.8+/-0.1%).
Possesses cholinergic properties, but is unlikely to be practically significant due to the concentrations required (unless bioavailability is otherwise enhanced)
One study in obese (TSOD) and lean (TSNO) mice given 1% or 3% of their feed as Kaempferia Parviflora for 8 weeks noted that supplementation at either dose was able to preserve reaction latency to a pain test but only in the obese group; the authors hypothesized that TSOD obese mice developed diabetic neuropathy and that Kaempferia Parviflora attenuated these changes. The only human study to assess pain was a human study measuring the Rate of Perceived Exertion (RPE) on an exercise test, and found no effect with an acute bolus of 1.35g.
One study in sexually mature rats given 70mg/kg bodyweight Kaempferia parviflora daily noted that supplementation was able to increase mounting frequency and reduce ejaculatory latency (indicative of aphrodisiac effects) and was nonsignificantly additive with exercise; post ejaculatory latency was seemingly unaffected. This has been replciated elsewhere, but the hexane and aqueous extracts were ineffective at decreasing mounting and ejaculatory latency. Interestingly, one study using a higher dose (240mg/kg) noted inhibitory effects on aphrodisia in rats and one using 1g/kg noted no significant differences between groups.
Some evidence that 70mg/kg in rats (human dose of 11.2mg/kg ethanolic extract) is an aphrodisiac, while higher doses may be adverse; the increase in sexuality does not appear to be too remarkable in magnitude
In primary cultured rat cortical cells treated with high levels of glutamate (sufficient to bring controls 100% viability to 0%), 5‐Hydroxy‐3,7,3′,4′‐tetramethoxyflavone was found to be protective in a concentration dependent manner from 0.1uM (13.4+/-0.5% survival) to 10uM (63.4+/-1.4% survival). This was less protective than the active controls of CNQX and MK‐801, but of similar potency to Amino‐5‐phosphonovaleric acid (APV). Other methoxyflavones were either ineffective (TMF and 5‐Hydroxy‐3,7‐dimethoxyflavone) or less protective.
Moderate neuroprotection from one compound; practical relevance of oral supplementation unknown
A study in anaesthesized rats injected with 12.5 or 100mg/kg Kaempferia parviflora was shown to increase cGMP content of cardiac tissue at the higher dose (to a lesser degree than the active control of 4mg/kg Sidenafil) with no effect at 12.5mg/kg, and this via a NOS-cGMP pathway (abolished by L-NAME, an inhibitor of NOS). Concentrations of 100mcg/mL have been found to protect cardiac contracility after Ischemic injury, possibly secondary to anti-oxidant effects.
Flavanoids in Kaempferia parviflora can exert endothelium-dependent relaxation properties via a NO-cGMP pathway and inhibiting calcium-induced contractility, which may be due to the DMF content which works via the endothelium and work via multiple pathways (NO-cGMP and COX) but mostly calcium influx inhibition and facilitating potassium efflux.
Antioxidant effects are also attributed to methoxyflavones which have shown benefit in diabetic rats (high oxidant stress in endothelium) at an oral intake of 100mg/kg bodyweight; in this study which confirmed a DMF content, the supplemental Kaempferia almost normalized superoxide production (and indirectly preserved nitric oxide levels) in diabetic mice without influencing control mice.
1% Kaempferia parviflora in the diet of obese rats has been associated with a reduced feed intake, which although present at 2 weeks (nonsignificant at 20.5% decrease) it appears to extend over a prolonged period of time (being significant at 18% reduction at 8 weeks); 0.3% of the diet was ineffective, and this was determined to not be taste aversion (same effects via gavage). One other study in obese mice using 1% and 3% failed to note these effects, however.
In vitro, Kaempferia Parviflora appears to have pancreatic lipase inhibitory properties with an IC50 of 487μg/mL in regards to the whole plant; isolated constituents with inhibitory potential include 5-hydroxy-3,7-dimethoxyflavone (IC50 291μg/mL), 5-hydroxy-3,7,4′-tri-methoxyflavone (IC50 536μg/mL), 5-hydroxy-7,4′-dimethoxyflavone (IC50 220μg/mL), and 5-hydroxy-7-methoxyflavone (IC50 291μg/mL).
An in vitro study with preadipocytes during their differentiation phase appear to beneficially influence adipocyte differentiation without being ligands for PPARγ, as assessed by 1-3uM of methoxyflavones increasing triglyceride assumulation and lipid droplet staining. This appeared to mostly be due to 3,5,7,4′-tetramethoxyﬂavone and 3,5,7,3′,4′-pentamethoxyﬂavone, and despite not being a PPARγ agonist they induced activity of C/EBPβ and C/EBPδ.
In TSOD mice (metabolic syndrome model), 1% Kaempferia parviflora was able to slightly decrease liver triglyceride and cholesterol content without significantly affecting serum concentrations; a reduction in body weight was apparent over 8 weeks in TSOD mice given either 0.3% or 1% K.Parviflora although the control (TNOS) mice were still lighter. Dose dependent benefits to weight loss have been noted with 1% and 3% in another study using the same mouse model (TSOD) and again showed no significant effect in lean control mice.
Slight unremarkable anti-obese effects
In a study on untrained males given 1.35g of Kaempferia Parviflora 90 minutes before a Repeated Wingate test and time to exhaustion (65% VO2 max) failed to find any improvment on either test or in the rate of percieved exertion.
One intervention using either 25mg or 90mg Kaempferia parviflora (2.1% DMF, 3.1% TMF, 2.3% PMF) for 8 weeks in persons over 60 who were otherwise healthy noted that the 90mg group experienced improvements in the 30-second chair stand test (11% improvement) and the 6-minute walk test (5%) with the 25mg group not being statistically significant. Improvements did not occur in the grip tests or tandem (gait) tests, and the benefits were attributed to an improvement in oxidative markers.
The chloroform extract of Kaempferia parviflora appeared to be the most anti-inflammatory in macrophages (assessed via suppressing iNOS expression in response to the proinflammatory LPS stimuli) with an IC50 between 8.1-8.4μg/ml; anti-inflammatory properties were shared by many methoxyflavones, but the most potent ones appeared to be 5,7-dimethoxyflavone, trimethylapigenin, and tetramethylluteolin with IC50 values of 18μM or 5.1μg/mL, 15μM or 4.6μg/mL, and 26μM or 8.7μg/mL respectively. When compared to the reference compound of Parthenolide (active component of Feverfew with an IC50 of 0.31μg/mL and 1.1μM) they underperformed. The mechanism of these three anti-inflammatory methoxyflavones appears to be mixed on ERK and JNK (inhibition) with tetramethylluteolin being a SYK inhibitor. This suppression of iNOS has been noted elsewhere, alongside a small suppression of COX-2 mRNA, where PGE2 production can be inhibited with an IC50 value of 9.2μg/mL (ethanolic extract) mostly due to 5-hydroxy-3,7,3',4'-tetramethoxyflavone.
General anti-inflammatory effects against macrophage activation from inflammatory stimuli
Some methoxyflavones appear to be anti-allergic, as one in vitro study in RBL-2H3 Mast Cells noted that degranulation (a hallmark of allergic responses) was attenuated most potently by 5-hydroxy-3,7,3',4'-tetramethoxyﬂavone with an IC50 of 8uM followed by 5-hydroxy-7-methoxyﬂavone (20.6uM) and 5-hydroxy-7,4'-dimethoxyﬂavone (26uM). The overall rhizome ethanolic extract (concentrated methoxyflavones) had an IC50 of 10.9ug/mL, and it appears to be the most anti-allergic of the Zingiberaceae family according to one study.
Possible anti-allergic effects of unknown practical potency
The ethanolic extract of Kaempferia parviflora has been tested in an animal model of carrageenan-induced paw edema (biomarker of acute inflammation) and various extracts at 150mg/kg appeared to inhibit paw edema in the range of 6.01-25.31% with the active control of 10mg/kg Indomethacin inhibiting 10.75%.
In castrated male rats given 1,000mg/kg Kaempferia parviflora daily for 5 days, an increase of serum testosterone occurred independent of any changes in LH, Progresterone, or FSH and to the degree of 66% higher than control. Another study in adult male rats (not castrated) also failed to note significant changes to LH and FSH, while testosterone trended to be nonsignificantly reduced; oddly, this study noted an increase in the weight of the prostate but not levator ani (mixed results on androgenicity indpendent of serum testosterone).
A later study in sexually mature rats measuring the weight of the levator ani muscle (hypertrophy of this muscle correlated with overall androgenicity) found no significant improvemenet with supplementation at 70mg/kg, while exercise increased the weight slightly; this latter study did not measure serum testosterone. A lack of influence on the levator ani has been noted elsewhere at 70mg/kg.
3,5,7,3',4'-pentamethoxyflavone (PMF) at 0.3mM was able to relax pre-contracted human cavernosal strips from 100% contraction to 1.63+/-0.62%, and this was not inhibited with a cGMP inhibitor (ODQ), potassium channel blocker (TEA), nor an ATP channel blocker (glybenclamide); In a test of PDE5 inhibition, PMF failed to augment glyceryl trinitrate-induced relaxation while Viagra was effective. These results suggest the relaxing effects of PMF on the penis tissue are not mediated by NO, cGMP, nor potassium channels (common mechanisms of action for other drugs) and is unlikely to be a Rho-Kinase inhibitor, but appears to be a calcium channel inhibitor but may act by other (currently unknown) mechanisms.
Other constituents of Kaempferia parviflora appear to be PDE5 inhibitors (similar to Viagra and Horny Goat Weed's Icariin). When the extract was tested by itself at 50ug/mL, Kaempferia parviflora rhizome was able to inhibit 62.63+/-7.17% of PDE5 inhibitory value (out of 41 tested herbs, only Caesalpinia sappan stem (60.23+/-1.81%), Senna surattensis leaf (65.08+/-0.78%), Acacia auriculaeformis leaf (73.66+/-4.87%) and Boesenbergia rotunda rhizome (40.86+/-3.94%) were similar); K.Parviflora had an IC50 of 12.24+/-0.99ug/mL with the ethanolic extract. Isolated compounds and their individual PDE5 IC50 values are 10.64+/-2.09ug/mL (DMF), 37.38+/-1.15ug/mL (2,7,4'-trimethoxyflavone), 16.32+/-1.93ug/mL (3,5,7-trimethoxyflavone), and 30.41+/-2.34ug/mL (PMF); all underperforming relative to Viagra.
Has a variety of mechanisms which indicate that Thai Ginseng is pro-erectile, but the practical significance of these pro-erectile effects have not been recorded in vivo (the one aphrodisiac study did not measure effects on the Penile Erection Index; PEI)
Following oral ingestion of 750mg/kg ethanolic extract of Kaempferia parviflora (9.44, 9.75, and 10.58 mg/kg of PMF, TMF, and DMF) PMF reached with a Cmax of 0.50+/-0.31ug/g at a Tmax of 2.36+/-1.25 hours giving an AUC of 1.01+/-0.24ug/g/h, DMF reached with a Cmax of 0.91+/-0.44ug/g at a Tmax of 2.86+/-1.07 hours giving an AUC of 1.90+/-0.62ug/g/h, and TMF reached with a Cmax of 1.10+/-0.43ug/g at a Tmax of 3.14+/-1.07 hours giving an AUC of 1.96+/-0.67ug/g/h.
One study in rats given 70mg/kg bodyweight of the herb noted an increase in the weight of the seminal vesicles, epididymus, and levator ani muscles when paired with exercise; these results were more likely induced by exercise, as changes in the supplementation only group were minimal. This same oral dose was found to not significantly increase testicular weight when ethanolic, hexane, and water extracts were all tested despite the ethanolic group conferring aphrodisiac properties. An increase in blood flow through the spermatic artery was noted with this extract independent of changes in blood pressure or heart rate, which was deemed an acute effect.
Following oral ingestion of 750mg/kg ethanolic extract of Kaempferia parviflora (9.44, 9.75, and 10.58 mg/kg of PMF, TMF, and DMF) PMF reached with a Cmax of 3.10+/-1.78ug/g at a Tmax of 3.43+/-0.98 hours giving an AUC of 9.07+/-1.37ug/g/h, DMF reached with a Cmax of 3.85+/-1.45ug/g at a Tmax of 2.57+/-1.10 hours giving an AUC of 8.60+/-1.97ug/g/h, and TMF reached with a Cmax of 3.01+/-1.49ug/g at a Tmax of 2.64+/-1.38 hours giving an AUC of 7.83+/-0.33ug/g/h.
The three main methoxyflavones have been detected in the rat liver following oral administration
In a preliminary test of protection of liver cells against D-GalN-induced toxicity, 5,3′-dihydroxy-3,7,4'-trimethoxyﬂavone appeared to be more effective than Silybin (a constituent of Milk Thistle) in protecting the cells, with an IC50 of 18.4μM relative to Silybin's 38.8μM.
Following oral ingestion of 750mg/kg ethanolic extract of Kaempferia parviflora (9.44, 9.75, and 10.58 mg/kg of PMF, TMF, and DMF) PMF reached with a Cmax of 1.00+/-0.39ug/g at a Tmax of 3.43+/-0.98 hours giving an AUC of 2.03+/-0.67ug/g/h, DMF reached with a Cmax of 1.33+/-0.49ug/g at a Tmax of 3.43+/-0.98 hours giving an AUC of 2.51+/-0.68ug/g/h, and TMF reached with a Cmax of 1.64+/-0.59ug/g at a Tmax of 3.43+/-0.98 hours giving an AUC of 3.01+/-0.85ug/g/h.
Following oral ingestion of 750mg/kg ethanolic extract of Kaempferia parviflora (9.44, 9.75, and 10.58 mg/kg of PMF, TMF, and DMF) PMF reached with a Cmax of 2.23+/-1.13ug/g at a Tmax of 0.08+/-0.17 hours giving an AUC of 1.60+/-0.37ug/g/h, DMF reached with a Cmax of 2.00+/-1.20ug/g at a Tmax of 1.20+/-0.19 hours giving an AUC of 2.17+/-0.31ug/g/h, and TMF reached with a Cmax of 1.41+/-0.58ug/g at a Tmax of 1.76+/-0.19 hours giving an AUC of 1.88+/-0.35ug/g/h.
- Wasuntarawat C, et al. No effect of acute ingestion of Thai ginseng (Kaempferia parviflora) on sprint and endurance exercise performance in humans. J Sports Sci. (2010)
- Mekjaruskul C, Jay M, Sripanidkulchai B. Pharmacokinetics, Bioavailability, Tissue Distribution, Excretion, and Metabolite Identification of Methoxyflavones in Kaempferia parviflora Extract in Rats. Drug Metab Dispos. (2012)
- Chaipech S, et al. New flav-3-en-3-ol glycosides, kaempferiaosides C and D, and acetophenone glycosides, kaempferiaosides E and F, from the rhizomes of Kaempferia parviflora. J Nat Med. (2012)
- Nakao K, et al. Xanthine oxidase inhibitory activities and crystal structures of methoxyflavones from Kaempferia parviflora rhizome. Biol Pharm Bull. (2011)
- Sadhu SK, et al. Cadinane sesquiterpenes from Curcuma parviflora. J Nat Prod. (2009)
- Chaturapanich G, et al. Effects of Kaempferia parviflora extracts on reproductive parameters and spermatic blood flow in male rats. Reproduction. (2008)
- Sae-Wong C, et al. Suppressive effects of methoxyflavonoids isolated from Kaempferia parviflora on inducible nitric oxide synthase (iNOS) expression in RAW 264.7 cells. J Ethnopharmacol. (2011)
- Horikawa T, et al. Polymethoxyflavonoids from Kaempferia parviflora induce adipogenesis on 3T3-L1 preadipocytes by regulating transcription factors at an early stage of differentiation. Biol Pharm Bull. (2012)
- Chaipech S, et al. Structures of two new phenolic glycosides, kaempferiaosides A and B, and hepatoprotective constituents from the rhizomes of Kaempferia parviflora. Chem Pharm Bull (Tokyo). (2012)
- Moon HI, et al. Immunotoxicity activity of sesquiterpenoids from black galingale (Kaempferia parviflora Wall. Ex. Baker) against Aedes aegypti L. Immunopharmacol Immunotoxicol. (2011)
- Konkumnerd W, Karnchanatat A, Sangvanich P. A thermostable lectin from the rhizomes of Kaempferia parviflora. J Sci Food Agric. (2010)
- Kusirisin W, et al. Antioxidative activity, polyphenolic content and anti-glycation effect of some Thai medicinal plants traditionally used in diabetic patients. Med Chem. (2009)
- Azuma T, Tanaka Y, Kikuzaki H. Phenolic glycosides from Kaempferia parviflora. Phytochemistry. (2008)
- Mekjaruskul C, Jay M, Sripanidkulchai B. Modulatory effects of Kaempferia parviflora extract on mouse hepatic cytochrome P450 enzymes. J Ethnopharmacol. (2012)
- Sawasdee P, et al. Anticholinesterase activity of 7-methoxyflavones isolated from Kaempferia parviflora. Phytother Res. (2009)
- Akase T, et al. Antiobesity effects of Kaempferia parviflora in spontaneously obese type II diabetic mice. J Nat Med. (2011)
- Chaturapanich G, et al. Enhancement of aphrodisiac activity in male rats by ethanol extract of Kaempferia parviflora and exercise training. Andrologia. (2012)
- Sudwan P, et al. Effect of Kaempferia parviflora Wall. ex. Baker on sexual activity of male rats and its toxicity. Southeast Asian J Trop Med Public Health. (2006)
- Trisomboon H, et al. Oral administration of Kaempferia parviflora did not disturb male reproduction in rats. J Reprod Dev. (2008)
- Moon HI, et al. Protective effects of methoxyflavone derivatives from black galingale against glutamate induced neurotoxicity in primary cultured rat cortical cells. Phytother Res. (2011)
- Weerateerangkul P, et al. Effects of Kaempferia parviflora wall. ex. baker and sildenafil citrate on cGMP level, cardiac function, and intracellular Ca2+ regulation in rat hearts. J Cardiovasc Pharmacol. (2012)
- Malakul W, et al. The ethanolic extract of Kaempferia parviflora reduces ischaemic injury in rat isolated hearts. J Ethnopharmacol. (2011)
- Wattanapitayakul SK, et al. Vasorelaxation and antispasmodic effects of Kaempferia parviflora ethanolic extract in isolated rat organ studies. Fitoterapia. (2008)
- Tep-Areenan P, Sawasdee P, Randall M. Possible mechanisms of vasorelaxation for 5,7-dimethoxyflavone from Kaempferia parviflora in the rat aorta. Phytother Res. (2010)
- Malakul W, et al. Effects of Kaempferia parviflora Wall. Ex Baker on endothelial dysfunction in streptozotocin-induced diabetic rats. J Ethnopharmacol. (2011)
- Shimada T, et al. Preventive effect of Kaempferia parviflora ethyl acetate extract and its major components polymethoxyflavonoid on metabolic diseases. Fitoterapia. (2011)
- Wattanathorn J, et al. Positive Modulation Effect of 8-Week Consumption of Kaempferia parviflora on Health-Related Physical Fitness and Oxidative Status in Healthy Elderly Volunteers. Evid Based Complement Alternat Med. (2012)
- Sae-wong C, Tansakul P, Tewtrakul S. Anti-inflammatory mechanism of Kaempferia parviflora in murine macrophage cells (RAW 264.7) and in experimental animals. J Ethnopharmacol. (2009)
- Tewtrakul S, Subhadhirasakul S. Effects of compounds from Kaempferia parviflora on nitric oxide, prostaglandin E2 and tumor necrosis factor-alpha productions in RAW264.7 macrophage cells. J Ethnopharmacol. (2008)
- Tewtrakul S, Subhadhirasakul S, Kummee S. Anti-allergic activity of compounds from Kaempferia parviflora. J Ethnopharmacol. (2008)
- Tewtrakul S, Subhadhirasakul S. Anti-allergic activity of some selected plants in the Zingiberaceae family. J Ethnopharmacol. (2007)
- Trisomboon H, et al. Effect of daily treatment with Thai herb, Kaempferia parviflora, in Hershberger assay using castrated immature rats. J Reprod Dev. (2007)
- Temkitthawon P, et al. Kaempferia parviflora, a plant used in traditional medicine to enhance sexual performance contains large amounts of low affinity PDE5 inhibitors. J Ethnopharmacol. (2011)
- Jansakul C, et al. Relaxant mechanisms of 3, 5, 7, 3', 4'-pentamethoxyflavone on isolated human cavernosum. Eur J Pharmacol. (2012)